Health
Molecular brace traps two cancer-driving proteins to suppress prostate cancer growth in preclinical tests
Medical Xpress·November 11, 2026

Many modern cancer drugs typically target a specific protein or signaling pathway to treat tumors. Now, researchers at the University of Michigan Health Rogel Cancer Center are taking a new approach by throwing a molecular wrench into the machinery driving prostate cancer. In preclinical studies, this new approach demonstrated greater antitumor activity while sparing normal cells.
Read the full story at Medical Xpress →